2024 ATS Conference News Preview - 2

RSV accounted for 11.4% of
hospitalizations for COPD.*
Join us during ATS 2024 for our RSV Learning Lounge
Sunday, May 19, 2024
|
1:00-1:45 PM |
Industry Theater 3†
Navigating RSV in Adults: Insights into
Disease and Vaccination
Join us for a panel discussion with key experts and digital opinion leaders as they delve
into the wide-ranging topic of Respiratory Syncytial Virus (RSV) in adults. Explore the true
burden of RSV disease in adults, risk factors for severe disease in your patient population,
and public health implications of RSV. The panel experts will also discuss innovative social
and digital tactics to improve respiratory health literacy and considerations for RSV
vaccine implementation in the adult population following the ACIP's recommendation that
adults aged ≥60 years may receive a single dose of an RSV vaccine using shared clinical
decision-making.
†An Industry Theater presentation at the ATS 2024 International Conference. This presentation is sponsored by GSK. Due to regulatory restrictions,
this presentation is only available to attendees from the United States.
Payel Gupta, MD, FACAAI
Medical Director of Allergy, Asthma, Immunology and ENT at LifeMD
Assistant Clinical Professor at SUNY Downstate Medical Center
Brooklyn, NY
Chase S. Hall, MD
Assistant Professor, Pulmonary, Critical Care and Sleep Medicine
The University of Kansas Medical Center
Kansas City, KS
Italo M. Brown, MD, MPH
Assistant Professor, Emergency Medicine; Department of Emergency Medicine
Stanford University School of Medicine and Stanford Hospital
Palo Alto, CA
Trademarks owned or licensed by GSK
PSE-US-2588
*Among hospitalized adults aged ≥65 years and high-risk adults with chronic lung or heart disease
Falsey AR, et al. N Engl J Med. 2005;352:1749-59.
Visit the GSK US Medical Affairs
Portal to learn more about RSV.
gskusmedicalaffairs.com

https://gskusmedicalaffairs.com/vaccines/respiratory-syncytial-virus/

2024 ATS Conference News Preview

Table of Contents for the Digital Edition of 2024 ATS Conference News Preview